GlobalRPh Renal Dosing Masterv6.6
GlobalRPh source record

Spironolactone

READ THE SOURCE-SPECIFIC ANSWER

Renal guidance at a glance

Confirm the product, indication and renal measure. The selected summary is not a complete prescribing monograph.

Choose a source to read (1)

Display order is not a clinical ranking. Date of retrieval is not the label revision date. Sources are never merged into one regimen. Other sources and conflicts remain below.

Historical source

Original GlobalRPh source

Product / population
Preserved GlobalRPh source, not a freshly verified product label
Renal measure
Use the method specified in the original source

Historical source: not automatically current. Review current official labeling and separately attributed additions before use.

The qualitative contraindications and alternative interval table are distinct original statements. The alternative does not override a contraindication or potassium monitoring.

Usual Dosing (Adults)

Edema from CHF, cirrhosis or nephrotic syndrome: initially 100 mg/day once or divided; source range 25-200 mg/day. As sole diuretic continue the starting dose for at least 5 days before optimizing. Hypertension: start 50-100 mg/day once or divided; may combine with more proximally acting diuretics or other antihypertensives. Allow at least 2 weeks because maximal response may be delayed. Diuretic-induced hypokalemia: 25-100 mg/day when potassium supplementation or other potassium-sparing approaches are inappropriate.

Renal Dosing

The original contraindications are anuria, acute renal insufficiency, significant impairment of renal excretory function or hyperkalemia. It also lists an alternative: CrCl above 50 mL/min no change; 10-50, every 12-24 hours; below 10, avoid.

Hemodialysis

Avoid.

Source revision: Historical source; revision not established here | Retrieved: 2026-09-05. Retrieval date is not the revision date.

Source: https://globalrph.com/renal/spironolactone/

Scope: Preserved historical source; no fresh clinical approval GlobalRPh v6.6.

Full source card / provenance

All sources, comparison tools and evidence navigation
Source-first renal review

Evidence sources and renal implications

Choose a source to jump directly to its locally stored result. Qualitative precautions and evidence gaps remain visible even when no numerical clearance schedule is supplied.

Preserved GlobalRPh source

Preserved original GlobalRPh source

Preserved historical content; not revalidated as current prescribing guidance.

Renal method: Read the measure and population stated in the original source sections.
Retrieved: 2026-09-05

Source presence is not independent validation. A label mirror is not a second independent source; review the original reference and exact formulation.

Product / population check

Confirm the exact formulation before using a renal source

These links compare product identities, not interchangeable doses. A selected summary is not a complete prescribing monograph.

Source-quality holds
Find text within this drug
Find a term without leaving this drug

Search the stored clinical text

Locate a word or phrase within this drug's source summaries. Choose all sources or one source to focus the search. The selection never hides warnings or source text, changes a dose, or proves that a renal finding is absent.

Find:

Enter at least two characters. Searches stay on this page and are not saved or sent.

All source summaries, original wording and provenance
Before applying a renal protocol

Check the setting. Compare whole sources.

No patient-specific dose is calculated. Context choices only display reminders; they do not validate, hide or change any regimen.

Share a reproducible source review

Choose sources below, then open a print-ready comparison with product scope, renal method, dates and cautions. Links can pin the exact local cards; they never contain patient values or choose a dose.

Open / share selected sources

Only one eligible source version is stored here. No second source is inferred from a reference link. Independent corroboration is still needed.

Build a source-review outline for documentation

This creates a blank decision outline with the source identities you select, not a dose recommendation or completed clinical assessment. No patient fields are collected, saved or sent. Complete the clinical decisions in your approved documentation system.

Choose one or two sources above or use the source checkboxes below.

Renal-context checklist: population, kidney trend and dialysis

These prompts are a reading aid, not a prescription checklist or proof that all requirements have been met. No selections are stored or sent to a server.

Read the exact source scope, renal metric and date before selecting a row. No applicability assessment has been performed.

See source-specific renal methods and the clinical interpretation guide for the supporting context.

Go directly to the relevant source section

Renal dosing and precautions

Choose a source, then jump to its renal or dialysis section. These links locate stored text; they do not merge regimens or certify that sources agree.

No dialysis or renal heading shown? Read the complete source summary. Absence of a heading is not evidence that dose adjustment is unnecessary.

Compare or copy source versions

All content below is stored locally. Read a whole source version; do not combine its dose with another source's interval, renal metric or dialysis assumptions.

Historical source content is not a current prescription. Original GlobalRPh recommendations are preserved, not automatically certified as current. Product-label and professional additions below are separately attributed. Confirm indication, population, kidney-function method, monitoring and the full prescribing information before applying a regimen.

Important source distinctions

The qualitative contraindications and alternative interval table are distinct original statements. The alternative does not override a contraindication or potassium monitoring.

Locally stored source content

Original GlobalRPh protocol

Clinical facts and comments transcribed into a structured reading format. This is not a byte-for-byte HTML archive. Original source: https://globalrph.com/renal/spironolactone/

Usual Dosing (Adults)

Edema from CHF, cirrhosis or nephrotic syndrome: initially 100 mg/day once or divided; source range 25-200 mg/day. As sole diuretic continue the starting dose for at least 5 days before optimizing. Hypertension: start 50-100 mg/day once or divided; may combine with more proximally acting diuretics or other antihypertensives. Allow at least 2 weeks because maximal response may be delayed. Diuretic-induced hypokalemia: 25-100 mg/day when potassium supplementation or other potassium-sparing approaches are inappropriate.

GRPH-spironolactone-01 · Source section: Usual Dosing (Adults)Renal section finder

Renal Dosing

The original contraindications are anuria, acute renal insufficiency, significant impairment of renal excretory function or hyperkalemia. It also lists an alternative: CrCl above 50 mL/min no change; 10-50, every 12-24 hours; below 10, avoid.

GRPH-spironolactone-02 · Source section: Renal DosingRenal section finder

Provenance and preservation

Additional summaries stored on this page: 0 official-label, 0 RX List, 0 professional, 0 handbook. Empty additional-source groups are not shown. A missing layer is not a no-adjustment recommendation.

Original source
https://globalrph.com/renal/spironolactone/
Source retrieval
2026-09-05. This is not the source publication or label revision date.
Original source type
globalrph individual
Local text SHA-256
a40322c1466d002df3c49e53cdae4a701400783ac2d1faa822f6e4192cb017ca
Import versus clinical validation
Source-section locators identify where retained content came from. A source-section identifier does not assert that every numeric statement has been independently corroborated. The local text hash is not a hash of original HTML, an FDA PDF or SPL XML.

The original individual GlobalRPh pages commonly cite NIH/NLM DailyMed and instruct readers to review the applicable package insert for updates. That historical reference is preserved as context; it is not counted as an independently retrieved current label.

Read the full coverage report